The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 14, 2021
Filed:
Sep. 14, 2016
Applicant:
Hangzhou Solipharma Co., Ltd., Zhejiang, CN;
Inventors:
Assignee:
Hangzhou Solipharma Co., Ltd., Zhejiang, CN;
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/02 (2006.01); A61K 47/10 (2017.01); A61K 47/16 (2006.01); A61K 47/08 (2006.01); A61K 31/4245 (2006.01); A61K 9/08 (2006.01); A61K 9/19 (2006.01); A61P 37/06 (2006.01); A61P 11/00 (2006.01); A61P 1/00 (2006.01); A61P 19/02 (2006.01); A61P 25/28 (2006.01); C07D 271/06 (2006.01);
U.S. Cl.
CPC ...
C07D 271/06 (2013.01); A61K 9/08 (2013.01); A61K 31/4245 (2013.01); A61K 47/08 (2013.01); A61K 47/10 (2013.01); A61K 47/16 (2013.01); A61P 1/00 (2018.01); A61P 11/00 (2018.01); A61P 19/02 (2018.01); A61P 25/28 (2018.01); A61P 37/06 (2018.01); C07B 2200/13 (2013.01);
Abstract
The present invention relates to novel crystal forms of ozanimod. Compared with the prior art, the crystal forms of the present invention have one or more improved properties. The present invention also relates to preparation methods of the crystal forms, pharmaceutical compositions thereof and uses thereof for the manufacture of medicament for treating and/or preventing diseases or adverse conditions associated with modulation, activation, stimulation, inhibition or antagonization of selective sphingosine-1-phosphate (S1P) receptor.